Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3NUJ

Crystal Structure of HIV-1 Protease Mutant I54V with Antiviral Drug Amprenavir

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Synchrotron siteAPS
Beamline22-ID
Temperature [K]100
Detector technologyCCD
Collection date2007-11-08
DetectorMARMOSAIC 300 mm CCD
Wavelength(s)0.8
Spacegroup nameP 21 21 2
Unit cell lengths57.500, 86.000, 45.950
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution10.000 - 1.500
R-factor0.1494
R-free0.19700
Structure solution methodAB INITIO
RMSD bond length0.009
RMSD bond angle0.028
Data reduction softwareHKL-2000
Data scaling softwareHKL-2000
Phasing softwareMOLREP
Refinement softwareSHELXL-97
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]50.0001.550
High resolution limit [Å]1.5001.500
Rmerge0.0600.462
Number of reflections37222
<I/σ(I)>2.4
Completeness [%]99.799.2
Redundancy4.23.6
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, HANGING DROP5.4298Crystal was grown by the hanging-drop vapor-diffusion method at room temperature, from a 2.2 mg/ml protein solution at pH 5.4 with 0.13M NaCl, 0.1M NaOAc. The inhibitor was mixed with protease in a ratio 5:1, VAPOR DIFFUSION, HANGING DROP, temperature 298K

247035

PDB entries from 2026-01-07

PDB statisticsPDBj update infoContact PDBjnumon